Model
Edge
Antares Pharma, Inc.
0001016169
Filing type
8-K
Filing date
May 23, 2022
Updated
May 24, 2022 ยท 10:22 AM
Copy reference
Filing
8-K
Material Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Com
Exhibits
EX-3.1
EX-3.1
EX-3.2
EX-3.2